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ABSTRACT
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) has been used in clinical diagnostic laboratories for the identification 
of microorganisms. It has a relevant advantage compared to other methods in terms 
of speed to provide results, being an alternative for addressing restrictions in clinical 
diagnosis as it may replace or complement existing identification techniques. This is 
especially important because some rare microorganisms would be identified only by 
higher cost techniques which are not widely available, such as genetic sequencing. 
Thus, the present paper reports two cases in which uncommon microorganisms were 
identified effectively and quickly.
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Until recently, microbial identification in clinical diagnostic laboratories relied 
mainly on conventional phenotypic and gene sequencing identification techniques. 
The development of matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry (MALDI-TOF MS) devices has revolutionized the routine 
identification of microorganisms in clinical microbiology laboratories1. Thus, urinary 
tract infections (UTIs) and other infections caused by mycobacteria involving 
microorganisms that are uncommon in laboratory routine can be investigated.
The genus Mycobacterium consists of several species, including 
nontuberculous mycobacteria (NTM). The M. abscessus complex is a group 
of fast-growing, multiresistant and ubiquitous soil and water species that can 
cause infections more difficult to treat due to resistance to antimicrobial drugs. 
They are also resistant to the action of disinfectants and are responsible for 
post-surgery infections in almost all human organs2,3. Actinotignum schaalii 
is another rare microorganism that causes UTI and whose identification by 
traditional phenotypic testing is unusual, which may have obscured its role 
as a pathological agent for years.
Thus, considering the difficulties involved in the identification of these 
microorganisms, this paper reports a case of M. abscessus in peritoneal 
effluent culture and a case of A. schaalii in a patient with UTI.
CASE REPORT
A 61-year-old woman living in a municipality in Minas Gerais state, 
southeastern Brazil, presented with chronic renal failure undergoing periodic 
hemodialysis. She underwent peritoneal dialysis due to other acquired 
complications. She reported fever and abdominal pain; after collection, 
perversion of the peritoneal fluid was observed. Due to suspected infection, 
the catheter was withdrawn, the material was sent for analysis, and treatment 
was initiated with cefazolin and gentamicin. In the absence of clinical 
improvement, treatment was changed to vancomycin and ceftazidime, but 
her status remained unchanged.
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The collected peritoneal effluent was plated in 
blood agar (BAP) (bioMérieux, Brazil), with bacterial 
growth occurring after 48 hours at 37 °C (Figure 1). 
The colonies were assessed using the VITEK 
2 Compact (bioMérieux) automated system, but 
no microorganism was identified.
The colonies were then assessed using the 
VITEK MS (bioMérieux) automated system, which 
identified them as M. abscessus (99% reliability), 
as depicted by a characteristic protein fingerprint, 
not requiring the use of an extraction protocol. 
The identification was confirmed by polymerase chain 
reaction (PCR) followed by PCR-restriction fragment 
length polymorphism (PCR-RFLP), revealing the 
bands4. Based on the banding profile (Figure 2), the 
species was identified using an international database 
(http://app.chuv.ch/prasite/index.html). The primers 
used were TB11 (ACCAACGATGGTGTGTCCAT) 
and TB12 (CTTGTCGAACCGCATACCCT), with 
a coding sequence for a heat shock protein (HSP) 
recommended for identification of microorganisms of 
that genus. Genus and species were identified, but 
subspecies could not be determined with a sufficient 
degree of reliability.
In addition, there was a second unusual bacterial 
identification in our laboratory routine. A 67-year-old 
man living in a municipality in Paraná state, southern 
Brazil, had undergone surgery to remove the prostate 
approximately six months earlier due to a malignant 
tumor. In the postoperative period, he used a urinary 
catheter, which was manipulated by himself or by 
family members.
In July 2018, the patient was diagnosed with 
UTI caused by extended-spectrum β-lactamase 
(ESBL)-producing Klebsiella pneumoniae at a count 
above 100,000 CFU/mL. The treatment of choice 
was amikacin and imipenem, which led to clinical 
improvement and absence of pyuria. Therapeutic 
success was confirmed with a new urine culture 
showing a negative result.
Subsequently, in September 2018, symptoms of UTI 
reappeared. The clinician in charge opted for empiric 
treatment with sulfamethoxazole-trimethoprim, with 
no clinical response and maintenance of intermittent 
fever and pain during urination.
A urine sample was collected and plated onto 
blood agar and chromogenic agar media, showing 
no bacterial growth. Because of the patient’s history, 
a Gram stain was performed, revealing unusual 
Gram-positive coccobacilli. The sample was then 
plated onto blood agar and, after 72 hours of 
anaerobic incubation, showed bacterial growth above 
100,000 CFU/mL.
Based on the comparison of the super spectrum 
obtained with reference spectra from the SARAMIS 
Figure 1: Colonies of M. abscessus on a blood agar plate.
Figure 2: Representative PCR-RFLP result amplified from 
the clinical isolate, showing the use of enzymes HAE (first 
three columns) and BSTE (last three columns).
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database (bioMérieux), A. schaalii was identified with 
99.9% reliability. A Gram stain of the colonies was 
performed and Gram-positive coccobacillary forms 
were visualized by microscopy, which was consistent 
with the identification of the species (Figure 3).
In the absence of known standardization, antimicrobial 
susceptibility testing was not performed. Only the 
identification of the etiological agent was reported.
DISCUSSION
Among fast-growing mycobacteria, the M. abscessus 
complex has proved to be one of the most resistant 
to antibiotics, being involved in several types of 
community-acquired infections2. In this context, 
infections in patients on hemodialysis have been 
reported, with some progressing to widely disseminated 
diseases, demonstrating the virulence potential of those 
mycobacteria and their resistance to commonly used 
disinfectants, such as formaldehyde in concentrations 
below 2%. This represents an increased risk of 
infections associated with health care5. After the 
identification of the microorganism, vancomycin and 
piperacillin-tazobactam were prescribed for 7 days, 
which, in contrast to previous treatments, had a good 
response and led to the improvement in the clinical 
status of the patient. Such therapy differs from what 
is traditionally indicated, but the response has been 
satisfactory. Moreover, there is a lack of consensus on 
optimal antimicrobial agents and combination therapy 
as well as optimal treatment duration and introduction 
of new antimicrobial agents (e.g., tigecycline)6.
Figure 3: Gram staining (original magnification, ×1000) 
showing Gram-positive coccoid rods.
Figure 4: Colonial morphology of A. schaalii grown on 
a blood agar plate after 72 hours of incubation under 
anaerobic conditions at 37 °C.
Regarding UTI, clinical diagnostic laboratories 
usually incubate urine samples for 16 to 24 hours 
in aerobic conditions. This may be an impediment 
to A. schaalii isolation, as this is a facultative 
anaerobe that grows slowly (4 to 5 days) in blood 
agar medium enriched in 5% carbon dioxide or 
in anaerobic conditions7 (Figure 4). Studies have 
shown that this microorganism has infection rates 
that increase with age, being more common in 
patients over 60 years of age and with a history of 
UTI8, which is consistent with the characteristics of 
the patient of the present study.
Clinicians must consider the possibility of A. schaalii 
infection in patients predisposed to common or 
unexplained chronic UTI, especially if the microscopic 
result of the urine sample shows coccobacilli and 
leukocytes, with negative bacterial growth by aerobic 
culture and non-response treatment with ciprofloxacin 
or trimethoprim9. An erroneous diagnosis of Gardnerella 
vaginalis has also been reported in situations which 
the result was based only on Gram staining, colony 
appearance, and slow growth10.
With regard to treatment, two weeks of β-lactam 
is usually effective unless the patient has chronic 
prostatitis, in addition to 4 to 6 weeks of antibiotics that 
have the ability to cross the blood-prostate barrier11. 
Finally, for the present case report, the clinical status 
of the patient improved after therapy with imipenem 
was reinitiated.
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